My baseline for this stock is 15 cents
Anyone who has followed this stock from 2014 or earlier and witnessed the third FDA rejection and death-spiral-financing knows what I mean.
For the "new investors" --
* The company didn't expect the third FDA rejection and had no plan B. The current CEO had just become CEO -- it wasn't HIS fault -- and he was handed a flaming bag of dog doodie.
* The company, having no plan B, resorted to toxic lenders and death spiral financing. That means a TON of dilution and two reverse splits, each of which which was met with an instant PPS out-of-control plummet.
* in 2019, The current CEO somehow - SOMEHOW - pulled this company out of the hands of the toxic lenders and did a third R/S, but this time it was different:
-> no subsequent PPS plummet. PPS post-split was 15 cents and is currently DOUBLE.
-> minimal dilution. the O/S right now is still only 13 million!
-> uplisting! Say WHAT?
So when the PPS is at 30 cents and the O/S is at 13 million, I can only shake my head and wonder how the CEO did it. You NEVER see a pinksheet company rise from the ashes like this without a B/K and reorganization, wiping out current shareholders.
And when someone calls a 16% drop on low volume "tanking," I can only shake my head, period.
I haven't even mentioned today's PR.